Reproducibility of the Oxford Classification of IgA nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALIGA study cohort

MLA

Bellur, S., et al. Reproducibility of the Oxford Classification of IgA Nephropathy, Impact of Biopsy Scoring on Treatment Allocation and Clinical Relevance of Disagreements: Evidence from the VALIGA Study Cohort. Sept. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1032..b58b1c675bd8013565a6aeae774e2567&authtype=sso&custid=ns315887.

APA

Bellur, S., Roberts, I., Troyanov, S., Royal, V., Coppo, R., Cook, H., Cattran, D., Terroba, Y., Asunis, A., Bajema, I., Bertoni, E., Bruijn, J., Cannata-Ortiz, P., Casartelli, D., Di Palma, A., Ferrario, F., Fortunato, M., Furci, L., Gakiopoulou, H., … Tardanico, R. (2018). Reproducibility of the Oxford Classification of IgA nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALIGA study cohort.

Chicago

Bellur, S, Isd Roberts, S Troyanov, V Royal, R Coppo, Ht Cook, D Cattran, et al. 2018. “Reproducibility of the Oxford Classification of IgA Nephropathy, Impact of Biopsy Scoring on Treatment Allocation and Clinical Relevance of Disagreements: Evidence from the VALIGA Study Cohort,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1032..b58b1c675bd8013565a6aeae774e2567&authtype=sso&custid=ns315887.